Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with ...

The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Got knee pain? You're in good company. Unfortunately knee pain is fairly common and can affect a wide range of individuals, from advanced athletes to older individuals, says Steve Knauf, DC, executive ...

A next-generation obesity shot from Eli Lilly and Co. helped patients lose almost a quarter of their body weight, potentially ...

Lilly’s first Phase III results for retatrutide show unprecedented weight loss and marked reductions in osteoarthritis pain, ...

Experiencing persistent pain in both your shoulder and knee on the same side of your body can be perplexing. While these joints are anatomically distant and function independently, simultaneous ...

Each year, nearly half of all runners in the U.S. wrestle with some type of pain or injury. The most commonly affected area, totaling 27 percent of running injuries is—you guessed it—the knee. If you ...

If your knees ache when you walk, climb the stairs or even rest, it's easy to assume the joint itself is to blame. But, according to a leading orthopaedic surgeon, the problem might lie much higher up ...